CD47 and neoplasm: We verified that BoxA promotes UPR, DAMPs release, and CD47 surface depletion in several mouse and human tumor cell lines; most importantly, BoxA induces tumor rejection and immunization also in mice inoculated with colon carcinoma CT26 cells.